Tizona Therapeutics | Improving outcomes for people with cancer_Sports

Breaking New GroundImproving outcomes for people with cancer by translating novel scientific insights into first-in-class immunotherapiesResilient to Our CoreWith grit, expertise and passion, our scientists are enabling transformational shifts in cancer treatmentLearn more about our scienceWe’re in thisTogetherWe believe that through dedication and with teams that transcend corporate walls, we can transform patient livesmeet our leadership teamRecent NewsOctober14, 2021Tizona Initiates Phase 1b Expansion Study of TTX-080 in Advanced Refractory or ResistantMalignanciesSeptember15, 2020Tizona Appoints Christine O’Brien as Chief Executive OfficerJuly21, 2020Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 MillionView More NewsHomeAboutOur Vision Leadership Board of Directors Scientific Advisory Board Investors Partners IRS Form 8937 Our SciencePipeline Key Programs NewsPress Releases Team TizonaOur Values Culture and Benefits Job OpportunitiesScientist Scientist I Contact ©2022 Tizona Therapeutics, Inc. All rights reserved.Website Design: Hane Chow, Inc.